Hikma Pharmaceuticals Plc Notice of Results (9119Y)

TIDMHIK

RNS Number : 9119Y

Hikma Pharmaceuticals Plc

08 March 2017

Notice of results

LONDON, UK, 8 March 2017 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing pharmaceuticals company, will announce its preliminary financial results for the year ended 31 December 2016 on Wednesday 15 March 2017.

A presentation and webcast for analysts will be held at 9.30am GMT at Etc. Venues, 155 Bishopsgate, Liverpool St, London, EC2M 3YD.

To join via conference call please dial: +44 (0) 20 3003 2666

UK Toll Free Number: 0808 109 0700

The results presentation and a webcast recording of the event will be available on the Company's website at www.hikma.com or http://cache.merchantcantos.com/webcast/webcaster/4000/7464/16532/72130/Lobby/default.htm

Playback facility:

A playback of the conference call will be available up to 7 days after the presentation.

UK & International Number: +44 (0) 20 8196 1998

UK Toll-Free Number: 0800 633 8453

Replay PIN code: 1028952#

-ENDS-

Enquiries

 
 Hikma Pharmaceuticals PLC 
 Susan Ringdal, VP Corporate         +44 (0)20 7399 2760/+44 
  Strategy and Investor Relations     7776 477050 
 Lucinda Baker, Deputy Director      +44 (0)20 7399 2765/+44 
  of Investor Relations               7818 060211 
 
 FTI Consulting 
 Ben Atwell/Matthew Cole             +44 (0)20 3727 1000

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non--branded generic and in--licensed products. Hikma operates through three businesses: "Injectables", "Branded" and "Generics", based principally in the United States, the Middle East and North Africa ("MENA") and Europe. In 2015, Hikma achieved revenue of $1,440 million and profit attributable to shareholders of $252 million. For more information visit www.hikma.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORKMGGFKRLGNZM

(END) Dow Jones Newswires

March 08, 2017 11:01 ET (16:01 GMT)

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024